Robot assisted endoscope market to reach $4.85B by 2030

The robot assisted endoscope market is projected to grow from $2.63 billion in 2025 to $3 billion in 2026, with demand rising for minimally invasive surgery, better diagnostics, and more precise clinical intervention. The Business Research Company says North America led in 2025, while Asia-Pacific is expected to post the fastest growth through 2030.

Why it matters: - Robot-assisted endoscopy is gaining traction as hospitals look for more precise, less invasive ways to diagnose and treat gastrointestinal and other internal conditions. - The market’s growth points to broader adoption of medical robotics in procedures that need better visualization, control, and therapeutic accuracy. - Rising gastrointestinal disease burden is adding pressure on healthcare systems to use advanced diagnostic and treatment tools.

What happened: - The Business Research Company published a 2026 market report on the global robot assisted endoscope market. - The report estimates the market will rise from $2.63 billion in 2025 to $3 billion in 2026. - The report projects the market will reach $4.85 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region through the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - The market is forecast to grow at a 14.3% CAGR from 2025 to 2026. - The market is projected to grow at a 12.7% CAGR from 2026 to 2030. - Past growth has been driven by demand for minimally invasive surgical techniques, broader use of endoscopic diagnostics, improvements in medical robotics, higher hospital investment in robotic systems, and more gastrointestinal disorder cases. - Future growth is expected to come from robotic adoption in outpatient settings, stronger demand for precise diagnostic tools, expansion of AI-powered clinical decision support, more frequent use in complex procedures, and investment in healthcare automation. - Expected trends include more robot-assisted endoscopic procedures, greater use of AI-guided navigation, improved visualization and imaging, and higher therapeutic precision. - Robot-assisted endoscopy uses robotic systems to support endoscopic procedures. - The technology is designed to improve control and maneuverability during diagnostic or therapeutic interventions inside the body. - The approach combines robotic capabilities with traditional endoscopy to support more accurate and less invasive examination and treatment. - The report says the 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The report’s growth outlook suggests robot-assisted endoscopy is moving from niche innovation toward broader clinical adoption. - The emphasis on AI-guided navigation and outpatient use suggests the competitive focus is shifting from hardware alone to workflow efficiency and clinical decision support. - WHO data cited in the release underscores the market’s underlying demand driver: March 2024 WHO figures cited roughly 1.7 billion diarrheal disease cases worldwide each year, plus 443,832 deaths among children under 5 and 50,851 deaths among children ages 5 to 9. - The report links those disease burdens to the need for earlier intervention and better diagnostic precision.

What's next: - The market is expected to continue expanding through 2030 as healthcare providers adopt more robotic platforms and AI-enabled tools. - Emerging Asia-Pacific markets are expected to outpace other regions as healthcare infrastructure and awareness of minimally invasive treatment benefits grow. - The report positions robotic endoscopy as a growing part of hospital and outpatient care rather than a one-off specialty tool. - More product development should center on imaging, navigation, and procedural precision as buyers seek better clinical outcomes.